Relapsed/Refractory Burkitt Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Burkitt Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies (NCT05537766) | Kite, A Gilead Company | 2022-11-01 |
Track Relapsed/Refractory Burkitt Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.